0001552470-16-000001.txt : 20160725 0001552470-16-000001.hdr.sgml : 20160725 20160725144343 ACCESSION NUMBER: 0001552470-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20160725 DATE AS OF CHANGE: 20160725 EFFECTIVENESS DATE: 20160725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reviva Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001552470 IRS NUMBER: 204907893 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-267657 FILM NUMBER: 161781947 BUSINESS ADDRESS: STREET 1: 5941 OPTICAL COURT CITY: SAN JOSE STATE: CA ZIP: 95138 BUSINESS PHONE: 408-960-2209 MAIL ADDRESS: STREET 1: 5941 OPTICAL COURT CITY: SAN JOSE STATE: CA ZIP: 95138 D 1 primary_doc.xml X0707 D LIVE 0001552470 Reviva Pharmaceuticals, Inc. 3900 Freedom Circle, #101 Santa Clara CA CALIFORNIA 95054 408-960-2209 DELAWARE None None Corporation true Laxminarayan Bhat 3900 Freedom Circle, #101 Santa Clara CA CALIFORNIA 95054 Executive Officer Director Marc Cantillon 3900 Freedom Circle, #1 Santa Clara CA CALIFORNIA 95054 Executive Officer Pedr Jensen 3900 Freedom Circle, #101 Santa Clara CA CALIFORNIA 9504 Director Sarvajna Dwivedi 3900 Freedom Circle, #101 Santa Clara CA CALIFORNIA 95054 Director Pharmaceuticals Decline to Disclose 06c false 2016-07-11 false true true Issuance of Convertible Promissory Notes, the Preferred Stock issuable upon conversion thereof and the Common Stock issuable upon conversion thereof. false 25000 Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC 375 Rodman & Renshaw, a unit of H.C. Wainwright & Co, LLC 375 430 Park Ave. 4th Floor New York NY NEW YORK 10022 All States false 5000000 1154087 3845913 false 16 150000 true 0 0 false Reviva Pharmaceuticals, Inc. Laxminarayan Bhat Laxminarayan President & CEO 2016-07-25